Objective
The aim of DoReMi is to promote the sustainable integration of low dose risk research in Europe in order to aid the effective resolution of the key policy questions identified by the High Level Expert Group (HLEG) on Low Dose Risk Research (www.hleg.de). DoReMi provides an operational tool for the development of the proposed MELODI platform (Multidisciplinary European Low Dose Risk Re-search Initiative) consisting of major national bodies and research programmes that have long term commitment in low dose risk research in Europe. A Letter of Intent between the core members of MELODI has been signed in April 2009. During the project, new members are expected to join the Initiative.
The Joint Programme of Activities (JPA) of DoReMi includes: (i) a Joint Programme of Research (JPR) covering the issues outlined above and providing an overview of the needs for research infra-structures of pan-European interest and facilitating multilateral initiatives leading to better use and development of research infrastructures; (ii) a Joint Programme of Integration (JPI) to develop a coor-dinated European roadmap for the long term needs of the key players in Europe; and (iii) a Joint Pro-gramme for the Spreading of Excellence (JPSE), covering knowledge management, training and mo-bility and its implementation. The JPR focuses on the areas identified by the HLEG as the most prom-ising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivity and internal exposures will be addressed as cross cutting themes within the three main research areas. A substantial proportion of the JPA will be dedicated to the joint programme of research. The pro-gramme describes a multidisciplinary approach including interfaces with the broader biological toxico-logical and epidemiological communities. Strategic planning will be carried out in close collaboration with MELODI. The long term Strategic Research Agenda (SRA) will be developed by MELODI, whereas DoReMi research priorities are based on a shorter term Transitional Research Agenda (TRA), focusing on goals that are feasible to achieve within the 6 year project and areas where barriers need to be removed in order to proceed with the longer term strategic objectives.
Call for proposal
FP7-Fission-2009
See other projects for this call
Funding Scheme
NoE - Network of ExcellenceCoordinator
00880 Helsinki
Finland
Participants (37)
Participation ended
1221 Budapest
92260 Fontenay Aux Roses
85764 Neuherberg
75015 Paris 15
SE1 8UG London
27100 Pavia
00161 Roma
1160 Bruxelles
38226 Salzgitter
10691 Stockholm
08003 Barcelona
75231 Paris
91054 Erlangen
60323 Frankfurt Am Main
18055 Rostock
1433 As
1332 Osteraas
0456 Oslo
000196 Roma
039 3212 Rokkasho Mura
D07 H6K8 Dublin
3015 GD Rotterdam
OX3 OBP Oxford
UB8 3PH Uxbridge
1097 Budapest
14000 Praha
WA3 6TW Warrington
RG7 4PR Reading
66123 Saarbrucken
2333 ZA Leiden
85579 Neubiberg
80539 Muenchen
1504 Sofia
91 348 Lodz
01 163 Warszawa
31007 Krakow
LS2 7UE Leeds